Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Philippe Collet

Showing results (271-280 of 376) with videos related to

Pageof 38
Sort By:
Intensive Care Medicine|August 2, 2011
CPAP for acute cardiogenic pulmonary oedema from out-of-hospital to cardiac intensive care unit: a randomised multicentre studyLaurent Ducros, Damien Logeart, Eric Vicaut, et al.
Rheumatology (Oxford, England)|June 10, 2022
Severe Libman-Sacks endocarditis complicating antiphospholipid syndrome: a retrospective analysis of 23 operated casesNellie Bourse Chalvon, Nathalie Costedoat-Chalumeau, Jean-Loup Pennaforte, et al.
European Heart Journal|December 8, 2022
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on ThrombosisFelicita Andreotti, Tobias Geisler, Jean-Philippe Collet, et al.
European Heart Journal|July 2, 2011
Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failureFabrice Ivanes, Sophie Susen, Frédéric Mouquet, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 11, 2020
Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysisPaul Guedeney, Sabato Sorrentino, Gennaro Giustino, et al.
Journal of the American College of Cardiology|October 4, 2005
Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromesZiad Mallat, Ph Gabriel Steg, Joëlle Benessiano, et al.
European Heart Journal|April 6, 2021
Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart DiseaseJurrien Ten Berg, Dirk Sibbing, Bianca Rocca, et al.
Kardiologia Polska|January 5, 2016
[2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation]Marco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
Thrombosis and Haemostasis|May 20, 2016
P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction. The PRIVATE-ATLANTIC studyJohanne Silvain, Robert F Storey, Guillaume Cayla, et al.
Circulation. Cardiovascular Interventions|May 10, 2022
Coronary Angiographic Features and Major Adverse Cardiac or Cerebrovascular Events in People Living With Human Immunodeficiency Virus Presenting With Acute Coronary SyndromeRaphael Robert, Yves Cottin, Valérie Potard, et al.
Pageof 38

Showing results (271-280 of 376) with videos related to

Sort By:
Pageof 38
Intensive Care Medicine|August 2, 2011
CPAP for acute cardiogenic pulmonary oedema from out-of-hospital to cardiac intensive care unit: a randomised multicentre studyLaurent Ducros, Damien Logeart, Eric Vicaut, et al.
Rheumatology (Oxford, England)|June 10, 2022
Severe Libman-Sacks endocarditis complicating antiphospholipid syndrome: a retrospective analysis of 23 operated casesNellie Bourse Chalvon, Nathalie Costedoat-Chalumeau, Jean-Loup Pennaforte, et al.
European Heart Journal|December 8, 2022
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on ThrombosisFelicita Andreotti, Tobias Geisler, Jean-Philippe Collet, et al.
European Heart Journal|July 2, 2011
Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failureFabrice Ivanes, Sophie Susen, Frédéric Mouquet, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 11, 2020
Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysisPaul Guedeney, Sabato Sorrentino, Gennaro Giustino, et al.
Journal of the American College of Cardiology|October 4, 2005
Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromesZiad Mallat, Ph Gabriel Steg, Joëlle Benessiano, et al.
European Heart Journal|April 6, 2021
Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart DiseaseJurrien Ten Berg, Dirk Sibbing, Bianca Rocca, et al.
Kardiologia Polska|January 5, 2016
[2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation]Marco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
Thrombosis and Haemostasis|May 20, 2016
P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction. The PRIVATE-ATLANTIC studyJohanne Silvain, Robert F Storey, Guillaume Cayla, et al.
Circulation. Cardiovascular Interventions|May 10, 2022
Coronary Angiographic Features and Major Adverse Cardiac or Cerebrovascular Events in People Living With Human Immunodeficiency Virus Presenting With Acute Coronary SyndromeRaphael Robert, Yves Cottin, Valérie Potard, et al.
Pageof 38